Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2008
10/15/2008EP1411982B1 Modulators of p-selectin glycoprotein ligand 1
10/15/2008EP1397388B1 Fxiii subunit a detection for verifying serum sample
10/15/2008EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/15/2008EP1282703B1 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
10/15/2008EP1242456B1 Scfv antibodies against disease associated molecules
10/15/2008EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
10/15/2008EP1097944B1 Antibody against protein tyrosine phosphatase intracellular domains
10/15/2008EP1045906B1 Apo-2 ligand
10/15/2008EP0870036B1 Synthetic mammalian alpha-n-acetylglucosaminidase and genetic sequences encoding same
10/15/2008CN101287988A Methods and compositions for diagnosis and treatment of influenza
10/15/2008CN101287841A Anti-alpha(v)beta(6) antibodies and uses thereof
10/15/2008CN101287827A Amidases, nucleic acids encoding them and methods for making and using them
10/15/2008CN101287765A 基因修饰的抗体组成物 Gene-modified antibody composition
10/15/2008CN101287764A Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38
10/15/2008CN101287763A Chimeric antibodies with new world primate regions
10/15/2008CN101287762A Engineered antibodies with new world primate framework regions
10/15/2008CN101287761A Stable antibody formulation
10/15/2008CN101287760A Anti-IL13 human antibodies
10/15/2008CN101287759A Methods for treating and preventing fibrosis
10/15/2008CN101287758A Plexin D1 as a target for tumor diagnosis and therapy
10/15/2008CN101287756A Sclerostin binding agents
10/15/2008CN101287753A Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target
10/15/2008CN101287752A Antigenic peptides and their use
10/15/2008CN101287492A Anti-glypican-3 antibody
10/15/2008CN101285061A Fungal cell wall synthesis gene
10/15/2008CN101284875A X-type gluten subunit monoclonal antibody of high molecular weight and uses thereof
10/15/2008CN101284874A Peptide-based immunization therapy for treatment of atherosclerosis
10/15/2008CN101284873A Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2008CN100425695C Novel human Rab GTP enzyme, its coding sequence and application
10/14/2008US7435874 Expresion vector comprising nucleotide sequences coding resistance protein (R1) for use as tool in generating transgenic tomato with fungal resistance; disease resistant plants; biological pest control
10/14/2008US7435871 Transgenic animals bearing human Igλ light chain genes
10/14/2008US7435804 Solubilizing inclusion bodies in a detergent to release the ScFv antibody; oxidizing to form disulfide bonds; removing the detergent;precipitating the oxidized ScFv antibodies; dissolving the precipitated ScFv antibodies in a denaturing solution; immobilizing on solid support; renaturing, elution
10/14/2008US7435803 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases
10/14/2008US7435802 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury
10/14/2008US7435801 Antibodies and other ligands directed against KIR2DL4 receptor for production of interferon gamma
10/14/2008US7435800 Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation
10/14/2008US7435799 TNF-α binding molecules
10/14/2008US7435798 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in normal stomach, normal skin and kidney tumor
10/14/2008US7435797 Anti-HER2 antibody variants
10/14/2008US7435796 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders
10/14/2008US7435794 Methods and compositions for selectively cleaving DNA containing duplex nucleic acids in a complex nucleic acid mixture, and nuclease compositions for use in practicing the same
10/14/2008US7435721 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell
10/14/2008US7435719 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
10/14/2008US7435592 Compositions for allogeneic cell therapy
10/14/2008US7435590 Recognizes human epiregulin (hEPR); detection of human tumors which express hEPR
10/14/2008US7435554 Immunoglobulin specific to lung cancer cell surface protein for use as tool in detection and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics; antitumor agents
10/14/2008US7435553 Detecting and isolating cells that produce preferential protein; obtain cells, transfrom cells with vector containing preferential protein, detect protein on surface of cell, isolate cells displaying preferential protein
10/14/2008US7435552 Binding assays that use human T1R2 to identify potential taste modulators
10/14/2008US7435551 Monoclonal antibody which does not bind with a monomeric adiponectin (GBP28) but specifically binds with GBP28 having a trimer structure or aggregated GBP28 trimers by recognizing an epitope on the structure; especially for diagnosing type II diabetes at an early stage; measuring a level of adiponectin
10/14/2008US7435549 Method of identifying binding site domains that retain the capacity of binding to an epitope
10/14/2008US7435421 Derivatives of choline binding proteins for vaccines
10/14/2008US7435419 Methods of diagnosing and treating pre-eclampsia or eclampsia
10/14/2008US7435416 Anti-tumor antibody compositions and methods of use
10/14/2008US7435415 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
10/14/2008US7435414 Humanized antibody against S-surface antigen of hepatitis B virus
10/14/2008US7435413 Using blood coagulation factor to identify antibodies which modulate, prevent and treat tumors, inflammation, septic shock, hypotension and adult respiratory distress syndrome
10/14/2008US7435412 Using lymphocyte antigen binding profiles to diagnose and treat cancer; antitumor agents
10/14/2008US7435410 Methods of treatment with interferson and albumin fusion protein
10/09/2008WO2008121876A2 Non-fucosylated antibodies
10/09/2008WO2008121821A1 Treatment of hodgkins lymphoma
10/09/2008WO2008121721A2 Targeted delivery and expression of procoagulant hemostatic activity
10/09/2008WO2008121402A1 Methods and compositions for the treatment of proliferative diseases
10/09/2008WO2008121301A1 Crystalline anti-human il-12 antibodies
10/09/2008WO2008121160A2 Optimized antibodies that target cd5
10/09/2008WO2008121125A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
10/09/2008WO2008121007A1 Novel saratan polypeptides and polynucleotides and methods of use thereof
10/09/2008WO2008120684A1 Method for determining prognosis of acute central nervous system disorder
10/09/2008WO2008120203A2 Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases
10/09/2008WO2008120202A2 Antibodies, methods and kits for diagnosing and treating melanoma
10/09/2008WO2008120101A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases
10/09/2008WO2008119567A2 Cross-species-specific cd3-epsilon binding domain
10/09/2008WO2008119566A2 Cross-species-specific bispecific binders
10/09/2008WO2008119565A2 Cross-species-specific binding domain
10/09/2008WO2008119493A1 Composition of labeled and non-labeled monoclonal antibodies
10/09/2008WO2008119353A1 Bispecific antibodies and methods for production thereof
10/09/2008WO2008119258A1 A recombinant adenovirus useful for treating malignancy overexpressing proto-oncogene neu/erbb2
10/09/2008WO2008119096A1 Transcytotic immunoglobulin
10/09/2008WO2008100805A3 Anti-robo4 antibodies and uses therefor
10/09/2008WO2008098917A3 Novel antibodies against igf-ir
10/09/2008WO2008067495A3 Chemotherapeutic conjugates and methods of use
10/09/2008WO2008067283A3 Ovr110 antibody compositions and methods of use
10/09/2008WO2008042469A3 Knockout mice for different genes and their use for gene characterizatio
10/09/2008WO2008022295A3 Prlr-specific antibody and uses thereof
10/09/2008WO2008019131A3 Methods and compositions for treating ige-mediated diseases
10/09/2008WO2008019061A3 Anti-il-6 monoclonal antibodies and uses thereof
10/09/2008WO2007123737A3 Methods and compositions for localized secretion of anti-ctla-4 antibodies
10/09/2008WO2007118206A3 Canine influenza virus
10/09/2008WO2007101028A3 Method to produce enzymatically active recombinant endonucleases
10/09/2008WO2007095729A8 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/09/2008WO2007089419A3 Sequence of stro-1 antibody variable region
10/09/2008WO2007087289A3 Anti-fcrn antibodies for treatement of auto/allo immune conditions
10/09/2008WO2007084740A3 Tat-030 and methods of assessing and treating cancer
10/09/2008WO2007076091A3 Treatment of viral infections using a tissue factor inhibitor
10/09/2008WO2007005608A3 Il-12/p40 binding proteins
10/09/2008WO2006108051A3 Compositions and methods relating to alzheimer's disease
10/09/2008WO2005082004A3 Rationally designed antibodies having a domain-exchanged scaffold
10/09/2008US20080250513 Supplying deoxyguanosine for enzymatic synthesis of deoxyribonucleosides; monoclonal/polyclonal antibodies; host cells, plants, animals
10/09/2008US20080250343 Receiver content saving system
10/09/2008US20080249293 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
10/09/2008US20080249288 Recombinantly preparing antibody fusion for targeting and/or treating metabolic disorders
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 1494